Articles with "hematological toxicity" as a keyword



Photo from wikipedia

Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan

Sign Up to like & get
recommendations!
Published in 2018 at "Pharmacological Research"

DOI: 10.1016/j.phrs.2018.08.026

Abstract: ABSTRACT Preventing severe irinotecan‐induced adverse reactions would allow us to offer better treatment and improve patients’ quality of life. Transporters, metabolizing enzymes, and genes involved in the folate pathway have been associated with irinotecan‐induced toxicity.… read more here.

Keywords: treatment; adverse reactions; overall toxicity; toxicity ... See more keywords
Photo from wikipedia

Hematological toxicities associated with linezolid therapy in adults: key findings and clinical considerations

Sign Up to like & get
recommendations!
Published in 2023 at "Expert Review of Clinical Pharmacology"

DOI: 10.1080/17512433.2023.2181160

Abstract: ABSTRACT Introduction Linezolid can cause serious adverse effects including thrombocytopenia and anemia. Here, we focus specifically on linezolid-related hematological toxicity in adult patients requiring prolonged drug treatment. Areas covered We review the available evidence on… read more here.

Keywords: hematological toxicities; linezolid therapy; associated linezolid; thrombocytopenia ... See more keywords
Photo from wikipedia

RADT-45. EFFECT OF DIFFERENT RADIOTHERAPY TECHNIQUES ON HEMATOLOGICAL TOXICITY OF CRANIOSPINAL IRRADIATION

Sign Up to like & get
recommendations!
Published in 2020 at "Neuro-oncology"

DOI: 10.1093/neuonc/noaa215.798

Abstract: To investigate the effect of different radiotherapy techniques on hematological toxicity of craniospinal irradiation. A retrospective study involving changes in hematology during craniospinal irradiation were conducted. 79 patients were divided into observation group and control… read more here.

Keywords: craniospinal irradiation; radiotherapy; group; hematological toxicity ... See more keywords
Photo from wikipedia

OS05.7.A Absence of severe hematological toxicity during first line treatment predicts low chance on severe toxicity during second line alkylating chemotherapy in glioblastoma

Sign Up to like & get
recommendations!
Published in 2021 at "Neuro-Oncology"

DOI: 10.1093/neuonc/noab180.023

Abstract: Glioblastoma has an infiltrative growth pattern that makes complete resection of the tumor virtually impossible. Sooner or later the tumor progresses, even after aggressive treatment with maximal safe resection, radiotherapy and/or chemotherapy. Hematological toxicity is… read more here.

Keywords: 2nd line; line; hematological toxicity; toxicity ... See more keywords
Photo from wikipedia

Risk Associated with Severe Hematological Toxicity in Patients with Urothelial Cancer Receiving Combination Chemotherapy of Gemcitabine and Cisplatin

Sign Up to like & get
recommendations!
Published in 2020 at "Chemotherapy"

DOI: 10.1159/000508805

Abstract: Introduction: Combination chemotherapy of gemcitabine and cisplatin (GC) is the standard treatment for patients with urothelial cancer (UC). However, hematological toxicity is a major side effect of GC therapy in patients with UC. In particular,… read more here.

Keywords: chemotherapy; toxicity patients; risk factors; hematological toxicity ... See more keywords
Photo by _louisreed from unsplash

This Is a Title: Single-Center Data Report of Clhag Regimen for R/R-AML Patients

Sign Up to like & get
recommendations!
Published in 2020 at "Blood"

DOI: 10.1182/blood-2020-139708

Abstract: Objectives: To explore the synergistic effect of CLAG combination with HHT in cell experiments and to evaluate the effectiveness and safety of the CLHAG regimen for patients with relapsed/refractory acute myeloid leukemia(R/R-AML). Methods:In thecell experiments,… read more here.

Keywords: synergistic effect; clhag regimen; hematological toxicity; aml patients ... See more keywords
Photo by stayandroam from unsplash

In Vitro Antithrombotic, Hematological Toxicity, and Inhibitor Studies of Protocatechuic, Isovanillic, and p-Hydroxybenzoic Acids from Maclura tricuspidata (Carr.) Bur

Sign Up to like & get
recommendations!
Published in 2022 at "Molecules"

DOI: 10.3390/molecules27113496

Abstract: In blood coagulation, circulating platelets and coagulation factors are crucial for the primary process because thrombi are generated by fibrin clotting with fibrinogen, thrombin, FXIIIa, and platelet activation. Therefore, strategies to reduce the activity of… read more here.

Keywords: inhibition; carr bur; inhibition type; hematological toxicity ... See more keywords
Photo by roberto_sorin from unsplash

Cytidine deaminase 435C>T polymorphism relates to gemcitabine-platinum efficacy and hematological toxicity in Chinese non-small-cell lung cancer patients.

Sign Up to like & get
recommendations!
Published in 2021 at "Neoplasma"

DOI: 10.4149/neo_2021_201116n1229

Abstract: CDA 435C>T is reported as a functional SNP but there is no relevant research on the efficacy/hematological toxicity of gemcitabine-platinum treatment in Chinese non-small-cell lung cancer (NSCLC) patients. In this study, 63 patients who received… read more here.

Keywords: toxicity; efficacy hematological; cda 435c; gemcitabine platinum ... See more keywords
Photo from wikipedia

The Relation of Haplotype ATP-binding Cassette B1 and Glutathione S-transferase P1 A313G Genes with Hematological Toxicity in Indonesian Breast Cancer Patients Receiving Chemotherapy

Sign Up to like & get
recommendations!
Published in 2022 at "Oman Medical Journal"

DOI: 10.5001/omj.2022.36

Abstract: Objectives Hematological toxicity induced by chemotherapy is known to be caused by multiple factors, including genetic factors such as polymorphisms. The polymorphisms may occur in drug efflux transporter proteins and enzymes involved in drug metabolism.… read more here.

Keywords: breast cancer; cancer patients; toxicity; hematological toxicity ... See more keywords